CONMED Corporation

NYSE:CNMD Rapporto sulle azioni

Cap. di mercato: US$2.3b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

CONMED Performance dei guadagni passati

Il passato criteri di controllo 4/6

CONMED ha registrato una crescita degli utili a un tasso medio annuo di 6.8%, mentre il settore Medical Equipment ha registrato utili in crescita a un tasso medio annuo di 11.2%. I ricavi sono stati in crescita a un tasso medio annuo di 7.5%. Il ritorno sul capitale proprio di CONMED è 11.2% e ha margini netti di 7.7%.

Informazioni chiave

6.8%

Tasso di crescita degli utili

5.4%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore8.9%
Tasso di crescita dei ricavi7.5%
Rendimento del capitale proprio11.2%
Margine netto7.7%
Ultimo aggiornamento sui guadagni30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

Sep 12
Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Aug 15
CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

Jul 17
CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Jun 21

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Jun 01
There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

ConMed: Fairly Priced At Pre-Pandemic Market Cap

Sep 21

CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

Sep 03
CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Aug 18
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

CONMED declares $0.20 dividend

Aug 11

Ripartizione dei ricavi e delle spese

Come CONMED guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

NYSE:CNMD Ricavi, spese e utili (USD Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 241,2769951154
31 Mar 241,2628250954
31 Dec 231,2456450553
30 Sep 231,1695848651
30 Jun 231,1398847951
31 Mar 231,099-9446249
31 Dec 221,045-8143947
30 Sep 221,069-8344046
30 Jun 221,042-11442744
31 Mar 221,0206842044
31 Dec 211,0116341544
30 Sep 219896240544
30 Jun 219795439343
31 Mar 218811336940
31 Dec 208621037440
30 Sep 20874036941
30 Jun 20870037342
31 Mar 209513439145
31 Dec 199552938845
30 Sep 199332938344
30 Jun 199012837043
31 Mar 198763136141
31 Dec 188604135338
30 Sep 188407234936
30 Jun 188287334534
31 Mar 188127133732
31 Dec 177965533132
30 Sep 177781532332
30 Jun 177731631832
31 Mar 177691231732
31 Dec 167641531332
30 Sep 167501630631
30 Jun 167351730230
31 Mar 167222229229
31 Dec 157193028727
30 Sep 157233428728
30 Jun 157292729128
31 Mar 157363029627
31 Dec 147403230328
30 Sep 147473131027
30 Jun 147503530827
31 Mar 147533430927
31 Dec 137633631826
30 Sep 137563730826

Guadagni di qualità: CNMD ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di CNMD (7.7%) sono inferiori rispetto allo scorso anno (7.8%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di CNMD sono cresciuti del 6.8% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di CNMD nell'ultimo anno ( 11.7% ) supera la media quinquennale ( 6.8% all'anno).

Guadagni vs Settore: La crescita degli utili CNMD nell'ultimo anno ( 11.7% ) ha superato la percentuale del settore Medical Equipment 5.5%.


Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 11.2% ) di CNMD è considerato basso.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate